We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy of 308nm Excimer Laser in White Striae

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00361361
Recruitment Status : Completed
First Posted : August 8, 2006
Last Update Posted : February 20, 2008
Sponsor:
Information provided by:
Shahid Beheshti University of Medical Sciences

Brief Summary:
The purpose of this study is to determine whether 308nm Excimer Laser therapy are effective in the color correction of white striae.

Condition or disease Intervention/treatment Phase
White Striae Excimer Laser Device: Excimer Laser Therapy Phase 1

Detailed Description:
The use of excimer laser in modified program in white striae during a few months.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Efficacy of 308nm Excimer Laser in White Striae
Study Start Date : July 2006
Primary Completion Date : September 2006
Study Completion Date : October 2006

Intervention Details:
    Device: Excimer Laser Therapy
    excimer laser is a UV 308nm laser. repeated sessions (10 sessions) needed. once per week.


Primary Outcome Measures :
  1. Clinical darkening of striaes

Secondary Outcome Measures :
  1. Colorimetric assessment


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • White Striae

Exclusion Criteria:

  • Red Striae

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00361361


Locations
Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University
Tehran, Iran, Islamic Republic of, 19899
Sponsors and Collaborators
Shahid Beheshti University of Medical Sciences
Investigators
Study Director: Nima Ostovari, M.D. Shahid Beheshti University of Medical Sciences
Study Chair: Parviz Toossi, MD skin research center of shaheed-beheshti medical university

Responsible Party: Dr.Nima Ostovari
ClinicalTrials.gov Identifier: NCT00361361     History of Changes
Other Study ID Numbers: src-ost-1360
First Posted: August 8, 2006    Key Record Dates
Last Update Posted: February 20, 2008
Last Verified: November 2006